http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2721760-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4118daab4210fd7f95581e5090577b70 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 |
| filingDate | 2018-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_033d0c014df86e25c9cf5c93c0e04743 |
| publicationDate | 2019-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2721760-A1 |
| titleOfInvention | Oncological active compound |
| abstract | Oncological active compound. Constituted from the following ingredients as a percentage of the total volume: 46.499% Robinia honey, 50% pleuronectes platessa, 1% silybum marianum, 0.001% Molybdenum, 1% trifolium pratense, 1% rose and 0.5% Artemis flowers. |
| priorityDate | 2018-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.